Globalizing cutting edge technology in point-of-care patient blood management


DF64Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL).

The team acted as lead advisor to the shareholders of TEM Group throughout the sale process. This deal demonstrates the value and competitive advantage Oaklins provides in guiding the client in a very close personal relationship through all stages of the process.

Read more about the transaction, market trends, deal drivers and M&A valuation aspects.